FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval

The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval commitment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts